PR inside: SPRY IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ...
(PR-inside.com) NEW YORK CITY, NY / ACCESS Newswire / September 24, 2026 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) between March 9, 2026 and June 24, 2026, inclusive (the "Class Period"), of the important October 5, 2026 lead plaintiff deadline.
SO WHAT: If you purchased ARS Pharmaceuticals securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the ARS Pharmaceuticals class action, go to https://rosenlegal.com/cases/ars-pharma ... s-inc/join or call Phillip ..
https://reports.pr-inside.com/spry-impo ... 227106.htm
Copyright PR-Inside.com 2026
